Report Detail

Request for Sample of this report

Pharma & Healthcare Global Immunoglobulin G Antibody Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4604839
    • |
  • 02 August, 2024
    • |
  • Global
    • |
  • 107 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Immunoglobulin G Antibody Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.

Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Immunoglobulin G Antibody Therapeutics industry chain, the market status of Autoimmune (IgG1, IgG4), Tumor (IgG1, IgG4), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immunoglobulin G Antibody Therapeutics.
Regionally, the report analyzes the Immunoglobulin G Antibody Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immunoglobulin G Antibody Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Immunoglobulin G Antibody Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immunoglobulin G Antibody Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., IgG1, IgG4).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immunoglobulin G Antibody Therapeutics market.
Regional Analysis: The report involves examining the Immunoglobulin G Antibody Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immunoglobulin G Antibody Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Immunoglobulin G Antibody Therapeutics:
Company Analysis: Report covers individual Immunoglobulin G Antibody Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immunoglobulin G Antibody Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Autoimmune, Tumor).
Technology Analysis: Report covers specific technologies relevant to Immunoglobulin G Antibody Therapeutics. It assesses the current state, advancements, and potential future developments in Immunoglobulin G Antibody Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immunoglobulin G Antibody Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Immunoglobulin G Antibody Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
IgG1
IgG4
Others
Market segment by Application
Autoimmune
Tumor
Others
Market segment by players, this report covers
Roche
Abbvie
J & J
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immunoglobulin G Antibody Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immunoglobulin G Antibody Therapeutics, with revenue, gross margin and global market share of Immunoglobulin G Antibody Therapeutics from 2019 to 2024.
Chapter 3, the Immunoglobulin G Antibody Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immunoglobulin G Antibody Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immunoglobulin G Antibody Therapeutics.
Chapter 13, to describe Immunoglobulin G Antibody Therapeutics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Immunoglobulin G Antibody Therapeutics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Immunoglobulin G Antibody Therapeutics by Type
    • 1.3.1 Overview: Global Immunoglobulin G Antibody Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Immunoglobulin G Antibody Therapeutics Consumption Value Market Share by Type in 2023
    • 1.3.3 IgG1
    • 1.3.4 IgG4
    • 1.3.5 Others
  • 1.4 Global Immunoglobulin G Antibody Therapeutics Market by Application
    • 1.4.1 Overview: Global Immunoglobulin G Antibody Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Autoimmune
    • 1.4.3 Tumor
    • 1.4.4 Others
  • 1.5 Global Immunoglobulin G Antibody Therapeutics Market Size & Forecast
  • 1.6 Global Immunoglobulin G Antibody Therapeutics Market Size and Forecast by Region
    • 1.6.1 Global Immunoglobulin G Antibody Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Immunoglobulin G Antibody Therapeutics Market Size by Region, (2019-2030)
    • 1.6.3 North America Immunoglobulin G Antibody Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Immunoglobulin G Antibody Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.6 South America Immunoglobulin G Antibody Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Immunoglobulin G Antibody Therapeutics Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Immunoglobulin G Antibody Therapeutics Product and Solutions
    • 2.1.4 Roche Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Abbvie
    • 2.2.1 Abbvie Details
    • 2.2.2 Abbvie Major Business
    • 2.2.3 Abbvie Immunoglobulin G Antibody Therapeutics Product and Solutions
    • 2.2.4 Abbvie Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Abbvie Recent Developments and Future Plans
  • 2.3 J & J
    • 2.3.1 J & J Details
    • 2.3.2 J & J Major Business
    • 2.3.3 J & J Immunoglobulin G Antibody Therapeutics Product and Solutions
    • 2.3.4 J & J Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 J & J Recent Developments and Future Plans
  • 2.4 Bristol-Myers Squibb
    • 2.4.1 Bristol-Myers Squibb Details
    • 2.4.2 Bristol-Myers Squibb Major Business
    • 2.4.3 Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Product and Solutions
    • 2.4.4 Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis Immunoglobulin G Antibody Therapeutics Product and Solutions
    • 2.5.4 Novartis Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Novartis Recent Developments and Future Plans
  • 2.6 Merck
    • 2.6.1 Merck Details
    • 2.6.2 Merck Major Business
    • 2.6.3 Merck Immunoglobulin G Antibody Therapeutics Product and Solutions
    • 2.6.4 Merck Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Merck Recent Developments and Future Plans
  • 2.7 Alexion Pharmaceuticals
    • 2.7.1 Alexion Pharmaceuticals Details
    • 2.7.2 Alexion Pharmaceuticals Major Business
    • 2.7.3 Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Product and Solutions
    • 2.7.4 Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Alexion Pharmaceuticals Recent Developments and Future Plans
  • 2.8 Takeda
    • 2.8.1 Takeda Details
    • 2.8.2 Takeda Major Business
    • 2.8.3 Takeda Immunoglobulin G Antibody Therapeutics Product and Solutions
    • 2.8.4 Takeda Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Takeda Recent Developments and Future Plans
  • 2.9 Amgen
    • 2.9.1 Amgen Details
    • 2.9.2 Amgen Major Business
    • 2.9.3 Amgen Immunoglobulin G Antibody Therapeutics Product and Solutions
    • 2.9.4 Amgen Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Amgen Recent Developments and Future Plans
  • 2.10 Biogen
    • 2.10.1 Biogen Details
    • 2.10.2 Biogen Major Business
    • 2.10.3 Biogen Immunoglobulin G Antibody Therapeutics Product and Solutions
    • 2.10.4 Biogen Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Biogen Recent Developments and Future Plans
  • 2.11 UCB
    • 2.11.1 UCB Details
    • 2.11.2 UCB Major Business
    • 2.11.3 UCB Immunoglobulin G Antibody Therapeutics Product and Solutions
    • 2.11.4 UCB Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 UCB Recent Developments and Future Plans
  • 2.12 Eli Lilly and Company
    • 2.12.1 Eli Lilly and Company Details
    • 2.12.2 Eli Lilly and Company Major Business
    • 2.12.3 Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Product and Solutions
    • 2.12.4 Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Eli Lilly and Company Recent Developments and Future Plans
  • 2.13 AstraZeneca
    • 2.13.1 AstraZeneca Details
    • 2.13.2 AstraZeneca Major Business
    • 2.13.3 AstraZeneca Immunoglobulin G Antibody Therapeutics Product and Solutions
    • 2.13.4 AstraZeneca Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 AstraZeneca Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Immunoglobulin G Antibody Therapeutics Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Immunoglobulin G Antibody Therapeutics by Company Revenue
    • 3.2.2 Top 3 Immunoglobulin G Antibody Therapeutics Players Market Share in 2023
    • 3.2.3 Top 6 Immunoglobulin G Antibody Therapeutics Players Market Share in 2023
  • 3.3 Immunoglobulin G Antibody Therapeutics Market: Overall Company Footprint Analysis
    • 3.3.1 Immunoglobulin G Antibody Therapeutics Market: Region Footprint
    • 3.3.2 Immunoglobulin G Antibody Therapeutics Market: Company Product Type Footprint
    • 3.3.3 Immunoglobulin G Antibody Therapeutics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Immunoglobulin G Antibody Therapeutics Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Immunoglobulin G Antibody Therapeutics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Immunoglobulin G Antibody Therapeutics Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Immunoglobulin G Antibody Therapeutics Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Immunoglobulin G Antibody Therapeutics Consumption Value by Type (2019-2030)
  • 6.2 North America Immunoglobulin G Antibody Therapeutics Consumption Value by Application (2019-2030)
  • 6.3 North America Immunoglobulin G Antibody Therapeutics Market Size by Country
    • 6.3.1 North America Immunoglobulin G Antibody Therapeutics Consumption Value by Country (2019-2030)
    • 6.3.2 United States Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Immunoglobulin G Antibody Therapeutics Consumption Value by Type (2019-2030)
  • 7.2 Europe Immunoglobulin G Antibody Therapeutics Consumption Value by Application (2019-2030)
  • 7.3 Europe Immunoglobulin G Antibody Therapeutics Market Size by Country
    • 7.3.1 Europe Immunoglobulin G Antibody Therapeutics Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.3 France Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Immunoglobulin G Antibody Therapeutics Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Immunoglobulin G Antibody Therapeutics Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region
    • 8.3.1 Asia-Pacific Immunoglobulin G Antibody Therapeutics Consumption Value by Region (2019-2030)
    • 8.3.2 China Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.5 India Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Immunoglobulin G Antibody Therapeutics Consumption Value by Type (2019-2030)
  • 9.2 South America Immunoglobulin G Antibody Therapeutics Consumption Value by Application (2019-2030)
  • 9.3 South America Immunoglobulin G Antibody Therapeutics Market Size by Country
    • 9.3.1 South America Immunoglobulin G Antibody Therapeutics Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Immunoglobulin G Antibody Therapeutics Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Immunoglobulin G Antibody Therapeutics Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country
    • 10.3.1 Middle East & Africa Immunoglobulin G Antibody Therapeutics Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Immunoglobulin G Antibody Therapeutics Market Drivers
  • 11.2 Immunoglobulin G Antibody Therapeutics Market Restraints
  • 11.3 Immunoglobulin G Antibody Therapeutics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Immunoglobulin G Antibody Therapeutics Industry Chain
  • 12.2 Immunoglobulin G Antibody Therapeutics Upstream Analysis
  • 12.3 Immunoglobulin G Antibody Therapeutics Midstream Analysis
  • 12.4 Immunoglobulin G Antibody Therapeutics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Immunoglobulin G Antibody Therapeutics. Industry analysis & Market Report on Immunoglobulin G Antibody Therapeutics is a syndicated market report, published as Global Immunoglobulin G Antibody Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Immunoglobulin G Antibody Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,634.36
    		3,951.54
    		5,268.72
    		3,132.00
    		4,698.00
    		6,264.00
    		494,682.00
    		742,023.00
    		989,364.00
    		291,380.40
    		437,070.60
    		582,760.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo